Resuscitation Outcomes Consortium - Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and Methodology Behind an Out-of-Hospital Cardiac Arrest Antiarrhythmic Drug Trial

Ítems similars

• Antiarrhythmic Drugs for Non-shockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS)
  per: Kudenchuk, Peter J., et al.
  Publicat: (2017)
• Effects of Intra-Resuscitation Antiarrhythmic Administration on Rearrest Occurrence and Intra-Resuscitation ECG Characteristics in the ROC ALPS Trial
  per: Salcido, David D., et al.
  Publicat: (2018)
• Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest
  per: Daya, Mohamud R., et al.
  Publicat: (2020)
• Resuscitation Outcomes Consortium (ROC) PRIMED Cardiac Arrest Trial Methods Part 2: Rationale and Methodology for “Analyze Later” Protocol
  per: Stiell, Ian G., et al.
  Publicat: (2008)
• Compression-to-Ventilation Ratio and Incidence of Rearrest – A Secondary Analysis of the ROC CCC Trial
  per: Salcido, David D., et al.
  Publicat: (2017)